{"success":true,"data":{"pressRelease":{"id":"153284","rtpr_id":"nPRrP5496a-20260925","ticker":"BIOGW","exchange":"LSE","all_tickers":["BIOGW"],"title":"REG-The Biotech Growth Trust PLC: Transaction in Own Shares","author":"PR Newswire","published_at":"2026-09-25T16:34:12.036Z","article_body":"For immediate release\n\n25 September 2026\nTHE BIOTECH GROWTH TRUST PLC\n(the \"Company\")\n\n \n\n \n\nMARKET PURCHASE OF COMPANY'S OWN SHARES\n\n \n\n \n\n \n\nNotification is given, pursuant to the authority granted at the Annual General\nMeeting of the Company held on 16 July 2026 to make market purchases of the\nCompany's own shares up to an aggregate maximum of 2,864,231 that a market\ntotal of 69,308 Ordinary shares of 25p each in the capital of the Company were\npurchased today for cancellation by the Company at a price of 1578.19 pence\nper share.\n\n \n\nFollowing this transaction, the Company hereby notifies the market that the\ntotal number of Ordinary shares that the Company has in issue, less the total\nnumber of Ordinary shares bought back for cancellation by the Company\nfollowing such purchase, and therefore, the total number of voting rights in\nthe Company 18,815,240. The Company does not currently hold any Ordinary\nshares in treasury.\n\n \n\nThe figure of 18,815,240 may be used by shareholders as the denominator for\nthe calculation by which they may determine if they are required to notify\ntheir interest in, or change to their interest in, the Company under the FCA's\nDisclosure Guidance and Transparency Rules.\n\n \nFor and on behalf of\nFrostrow Capital LLP\n\nCompany Secretary\n\n \n\nFor further information, please contact:\n\n \n\nKatherine Manson\n\nFrostrow Capital LLP\n\nTel: 020 3709 8734\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPRrP5496a-20260925","title":"REG-The Biotech Growth Trust PLC: Transaction in Own Shares","author":"PR Newswire","ticker":"BIOGW","created":"2026-09-25T16:34:12.036Z","tickers":["BIOGW"],"exchange":"LSE","article_body":"For immediate release\n\n25 September 2026\nTHE BIOTECH GROWTH TRUST PLC\n(the \"Company\")\n\n \n\n \n\nMARKET PURCHASE OF COMPANY'S OWN SHARES\n\n \n\n \n\n \n\nNotification is given, pursuant to the authority granted at the Annual General\nMeeting of the Company held on 16 July 2026 to make market purchases of the\nCompany's own shares up to an aggregate maximum of 2,864,231 that a market\ntotal of 69,308 Ordinary shares of 25p each in the capital of the Company were\npurchased today for cancellation by the Company at a price of 1578.19 pence\nper share.\n\n \n\nFollowing this transaction, the Company hereby notifies the market that the\ntotal number of Ordinary shares that the Company has in issue, less the total\nnumber of Ordinary shares bought back for cancellation by the Company\nfollowing such purchase, and therefore, the total number of voting rights in\nthe Company 18,815,240. The Company does not currently hold any Ordinary\nshares in treasury.\n\n \n\nThe figure of 18,815,240 may be used by shareholders as the denominator for\nthe calculation by which they may determine if they are required to notify\ntheir interest in, or change to their interest in, the Company under the FCA's\nDisclosure Guidance and Transparency Rules.\n\n \nFor and on behalf of\nFrostrow Capital LLP\n\nCompany Secretary\n\n \n\nFor further information, please contact:\n\n \n\nKatherine Manson\n\nFrostrow Capital LLP\n\nTel: 020 3709 8734\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-09-25T16:34:12.071566161Z","server_sent_at_ms":1790354052071},"received_at":"2026-09-25T16:34:12.122Z","source_url":null},"analysis":{"id":"142086","press_release_id":"153284","analysis_json":{"industry":{"label":"Capital Markets","sector":"Financials"},"redFlags":[],"eventType":"buyback","narrative":"The Biotech Growth Trust purchased 69,308 of its own ordinary shares at 1578.19p for cancellation, under its AGM-granted authority of up to 2,864,231 shares.\n\nPost-transaction, total voting rights stand at 18,815,240 shares, the denominator shareholders should use for disclosure notifications.\n\nThis is a routine daily buy-in notice for the closed-end trust with no strategic or financial signal.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine trust buyback disclosure -- suppress from feeds."},"keyFigures":{"customDimensions":{"purchase_price_pence":1578.19,"shares_authorized_max":2864231,"shares_purchased_today":69308,"voting_rights_denominator":18815240}},"namedEntities":{"people":[{"name":"Katherine Manson","role":"Frostrow Capital LLP contact"}],"products":[],"companies":[{"name":"The Biotech Growth Trust PLC","ticker":"BIOGW","relationship":"filer"},{"name":"Frostrow Capital LLP","relationship":"company secretary"}],"dollarAmounts":[{"amount":"1578.19 pence","context":"per-share purchase price for cancelled shares"}]},"materialImpact":{"score":1,"reasoning":"Routine daily buy-in disclosure under UK rules: 69,308 shares repurchased for cancellation out of a 2,864,231-share authority. Boilerplate for a closed-end investment trust."},"tickerRelevance":{"others":[],"primary":"BIOGW"},"globalImportance":8,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"micro-cap-closed-end-fund","eventGravity":"routine-buyback-disclosure","issuerAuthored":true}},"event_type":"buyback","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"The Biotech Growth Trust purchased 69,308 of its own ordinary shares at 1578.19p for cancellation, under its AGM-granted authority of up to 2,864,231 shares.\n\nPost-transaction, total voting rights stand at 18,815,240 shares, the denominator shareholders should use for disclosure notifications.\n\nThis is a routine daily buy-in notice for the closed-end trust with no strategic or financial signal.","key_figures":{"customDimensions":{"purchase_price_pence":1578.19,"shares_authorized_max":2864231,"shares_purchased_today":69308,"voting_rights_denominator":18815240}},"named_entities":{"people":[{"name":"Katherine Manson","role":"Frostrow Capital LLP contact"}],"products":[],"companies":[{"name":"The Biotech Growth Trust PLC","ticker":"BIOGW","relationship":"filer"},{"name":"Frostrow Capital LLP","relationship":"company secretary"}],"dollarAmounts":[{"amount":"1578.19 pence","context":"per-share purchase price for cancelled shares"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-25T16:34:16.469Z","global_importance":8,"audience_relevance":10,"importance_components":{"tickerTier":"micro-cap-closed-end-fund","eventGravity":"routine-buyback-disclosure","issuerAuthored":true}},"durationMs":4348,"modelName":"glm-5.3-flashx"}}